Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synthetic process of acipimox

A synthesis process and a technology for methylpyrazine, applied in the field of synthesis technology of acyclolimus, can solve the problems of high impurity content of crude product, reduced production efficiency, unstable process, etc., achieves reduction of production cost, simplified production process, reduced The effect of the number of crystals

Inactive Publication Date: 2018-04-06
SICHUAN YIMING PHARMA CO LTD
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above-mentioned process in the prior art not only has the disadvantage of extremely unstable process, but also produces a crude product with high impurity content, which needs to be recrystallized and purified before obtaining the finished acipimox product with the purity specified in the Pharmacopoeia
However, in the actual production process at present, due to the strict requirements on the operating conditions of recrystallization, the process is cumbersome, and takes a long time, which greatly reduces the production efficiency. Therefore, the above-mentioned process has obvious defects in actual industrial production, and its application has been greatly affected. limit

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic process of acipimox
  • Synthetic process of acipimox
  • Synthetic process of acipimox

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0027] In the process of studying the preparation process of acipimox, the present inventors discovered unexpectedly through a large number of screening tests: after the reaction mother liquor obtained in the existing acipimox synthesis process is processed by some specific auxiliary agents, Then add activated carbon for decolorization treatment, and a qualified finished product can be obtained through one cooling crystallization. The above process can effectively reduce the number of crystallization times and avoid recrystallization operations, thus greatly simplifying the production process, improving the synthesis yield, and reducing the overall cost.

[0028] Specifically, the present invention provides:

[0029] A synthesis process of acipimox, which comprises:

[0030] 1) In an aqueous solution, under the action of a catalyst, 5-methylpyrazine-2-carboxylic acid and hydrogen peroxide react as shown in the following formula II,

[0031]

[0032] 2) adding an auxiliary...

Embodiment 1

[0056] Add 6.2g (19mmol) of sodium tungstate dihydrate into a 1L reaction flask, add 400ml of water, stir to dissolve, add 1.9g (19mmol) of concentrated sulfuric acid while stirring, and continue to add 204g (1.8mol) of hydrogen peroxide (30%), Stir evenly, add 207.2g (1.5mol) of 5-methylpyrazine-2-carboxylic acid, heat in a water bath to 60°C, keep stirring for 8 hours, add 31.2g (0.3mol) of sodium bisulfite, and continue stirring for 1 hour. Add 12 g of activated carbon, continue to stir for 1 hour, filter while it is hot, cool the filtrate to 4 ° C, keep for 3 hours, filter, and dry the filter cake at 100 ° C for 3 hours to obtain 196.2 g of off-white crystalline powder with a HPLC purity of 99.35%. The rate is 84.9%.

Embodiment 2

[0058] Add 6.2g (19mmol) of sodium tungstate dihydrate into a 1L reaction flask, add 400ml of water, stir to dissolve, add 1.9g (19mmol) of concentrated sulfuric acid while stirring, and continue to add 306g (2.7mol) of hydrogen peroxide (30%), Stir evenly, add 207.2g (1.5mol) of 5-methylpyrazine-2-carboxylic acid, heat in a water bath to 80°C, keep stirring for 4 hours, add 151.2g (1.2mol) of sodium sulfite, continue stirring for 0.5 hours, and add 20g of activated carbon , continue to stir for 1 hour, filter while hot, cool the filtrate to -4 ° C, keep for 3 hours, filter, and dry the filter cake at 80 ° C for 3 hours to obtain 192.2 g of off-white crystalline powder, HPLC purity 99.1%, yield 83.1 %.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a synthesis process of acipimox, which comprises: 1) in an aqueous solution, under the action of a catalyst, reacting 5-methylpyrazine-2-carboxylic acid with hydrogen peroxide; Step 1) Add an auxiliary agent to the solution obtained, wherein the auxiliary agent is selected from one of sulfite, bisulfite, oxalic acid and oxalate; 3) Add to the solution obtained in step 2) Activated carbon, filter; and 4) The solution obtained in step 3) is cooled to crystallize and dried to obtain the finished product of acipimox. The synthesis process of the invention can effectively reduce the number of crystallization times, avoid recrystallization operation, improve yield and reduce production cost.

Description

technical field [0001] The invention belongs to the field of pharmacy, and in particular relates to a synthesis process of acipimox. Background technique [0002] Acipimox (Acipimox) is a kind of hypolipidemic drug developed and listed by Italian Farmitalia Carol Erba Company in 1985, which can inhibit the release of free fatty acids from adipose tissue, reduce blood very low density lipoprotein and low density lipoprotein, thereby It can reduce the concentration of triglyceride and cholesterol in the blood, and can also promote the increase of high-density lipoprotein, so it is mainly used to treat type II A, II R, III, IV and V hyperlipoproteinemia. It has the characteristics of strong lipid-lowering effect, less adverse reactions, good tolerance, suitable for long-term medication and the like. In addition, acilimus can also promote glucose metabolism in patients with non-insulin-dependent diabetes mellitus, which is related to lowering blood sugar; and can effectively re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D241/24
Inventor 唐良伟雍智全文薪沣闻亚磊滕德刚熊仕萍俞思勇张桂兴邓华蓉张兰
Owner SICHUAN YIMING PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com